Advanced Techniques for Cancer Imaging and Detection

描述（由申请人提供）：我们正在提交一个竞争更新我们的长期培训计划在斯坦福大学放射学下的一个新的名称，先进的技术，癌症成像和检测，以反映戏剧性的变化，这一计划已经经历了自我们上次申请。我们的部门是为数不多的已经能够扩大和拥抱必要的多学科视野，包括分子成像，纳米技术和系统生物学，以增强我们在解剖成像的实力之一。我们已经扩大了我们的设施，为我们的学员提供癌症成像和检测技术的经验，包括分子成像，纳米技术，超声，PET/CT，MRI和计算系统。我们的目标是提供M.D.和博士经过严格培训的博士后学生，致力于基于成像技术的癌症检测，诊断和治疗。自1993年以来，我们已经成功地毕业了21医学博士。和博士实习生所有的学员在他们的任期内在程序生产;许多继续在癌症成像学术活动今天。目前的六名受训人员正在进行乳腺癌磁共振成像和纳米颗粒血管生成成像的研究;开发用于诊断和治疗癌症的磁共振探针;以及培养先进的CT和分子成像仪器。 现在比1993年更需要这个方案。自2001年应用以来，放射学领域发生了巨大变化，现在比以往任何时候都在癌症患者的诊断和治疗中发挥着关键作用。我们的计划是非常致力于履行我们的使命，通过其独特的科学家，临床医生和教育工作者的混合培养下一代领导者在癌症成像和检测。我们计划的学员将受益于部门内的优秀资源，以及通过生物工程，放射肿瘤学，电气工程，材料科学，分子药理学，卫生政策和研究以及癌症生物学等学科提供的资源。 我们大幅扩展的计划将利用四个现有的卓越中心：体内细胞和分子成像中心（ICMIC@斯坦福大学）;癌症纳米技术卓越中心（CCNE）;先进磁共振技术中心（CAMRT）;和癌症生物学计算建模，这是综合癌症生物学计划（ICBP）规划补助金。其中三个中心是在过去三年中建立的。 博士加里M.格雷泽将继续指导该项目，该项目将由12位知名导师和7位杰出的项目顾问指导。学员必须参加临床癌症，成像科学，生物统计学和医学伦理学的课程，研讨会和会议。他们还必须完成原创的独立研究。

DESCRIPTION (provided by applicant): We are submitting a competing renewal for our longstanding training program in Stanford Radiology under a new name, Advanced Techniques for Cancer Imaging and Detection, to reflect the dramatic changes that this program has undergone since our last application. Our Department is one of the very few that has been able to expand and embrace a multidisciplinary vision necessary to encompass molecular imaging, nanotechnology, and systems biology to augment our strength in anatomic imaging. We have expanded our facilities to offer our trainees experience in cancer imaging and detection techniques that include molecular imaging, nanotechnology, ultrasound, PET/CT, MRI, and computational systems. Our goal is to provide M.D. and Ph.D. trained postdoctoral students with rigorous training towards a career in cancer detection, diagnosis, and therapy based on imaging techniques. Since 1993, we have successfully graduated 21 M.D. and Ph.D. trainees. All trainees were productive during their tenure in the program; many continue academic activity in cancer imaging today. The six current trainees are pursuing research in MR imaging of breast cancer and angiogenesis imaging with nanoparticles; developing MR probes for the diagnosis and treatment of cancer; and cultivating advanced instrumentation for CT and molecular imaging. The need for this program is even greater now than it was in 1993. Since our 2001 application, the field of radiology has dramatically changed and now, more than ever, plays a key role in the diagnosis and treatment of cancer patients. Our program is very committed to fulfilling our mission of training the next leaders in cancer imaging and detection through its unique blend of scientists, clinicians, and educators. Trainees in our program will benefit from the excellent resources within the Department and from those resources available through such disciplines as bioengineering, radiation oncology, electrical engineering, materials science, molecular pharmacology, health policy and research, and cancer biology. Our substantially expanded program will leverage four existing centers of excellence: the In Vivo Cellular and Molecular Imaging Center (ICMIC@Stanford); the Center of Cancer Nanotechnology Excellence (CCNE); the Center for Advanced Magnetic Resonance Technology (CAMRT); and the Computational Modeling of Cancer Biology, which is the Integrative Cancer Biology Program (ICBP) planning grant. Three of these centers have been developed in the last three years. Dr. Gary M. Glazer will continue to direct the program, which will be mentored by twelve established preceptors and seven distinguished program advisors. Trainees are required to participate in courses, seminars, and conferences in clinical cancer, the imaging sciences, biostatistics, and medical ethics. They are also required to complete original, independent research.